The document contains the tentative schedule for a two-day vaccine conference with sessions on various topics related to vaccine research and development. Day 1 includes sessions on bacterial vaccines, therapeutic vaccination, biotechnology, lung cancer vaccines, vaccine development and manufacturing, and track and trace systems for vaccines. Day 2 will cover topics like malaria vaccines, bacterial translocation and dengue, pathogen genes for vaccine development, zika virus vaccines, tuberculosis vaccines, and evaluations of vaccine logistics and immunization programs. There will be keynote speeches, oral presentations, poster presentations, and panel discussions over the two days with speakers from universities, research institutions, and pharmaceutical companies around the world.

1. 08:30-09:30 Registrations
09:30-10:00 Introduction & Opening Cermony
Plenary Sessions
Vaccines
Research &
Development
Sessions
Bacterial Vaccines
Therapeutic vaccination for Auto Immune Diseases
Biotechnology and Modern Vaccine Technology
Title: Tumor Liberated Protein (TLP) As Potential Vaccine For Non Small Cell
Lung Cancer (NSCLC) Patients
Giulio Tarro, Beaumont Bonelli Cancer Research, Italy
Title: Perspectives of Vaccine Development and Manufacture
Tony D' Amore, Sanofi Pasteur, Canada
11:20-11:35 @CoffeeBreak
Title: Track & Trace for Vaccines for Patient Safety
Ulrike Kreysa, GS1 Global Office, Belgium
Title: The Development of Low Cost Recombinant Bacterial Glycoconjugate
Vaccines
Brendan Wren, London School of Hygiene and Tropical Medicine, UK
12:55-13:00 Group Photo
13:00-14:00 @Lunch Break
Title: A Viral-Vectored Multi-Stage Malaria Vaccine Regimen with Protective
and Transmission-Blocking Efficacies
Shigeto Yoshida, Kanazawa University, Japan
Title: Accelerating Vaccine Process Development and Increasing Productivity
with Single Use Intensified Processing and Predictive Process Control
Jean-Marc Cappia, Head of Segment Marketing Vaccines at Sartorius Stedim
Biotech, France
Venue: Holiday Inn : Lisbon - Continental
14:40-15:20
Day 1 February 10, 2020
10:00-10:40
10:40-11:20
11:35-12:15
12:15-12:55
14:00-14:40

2. Title: Utilization of Anti-Somatostatin Vaccines for Multiple Species and
Regulatory Use
Keith N Haffer, Braasch Biotech LLC, United States
16:00-16:15 @Coffee Break
Session Chair Dr. Giulio Tarro, Italy
Session Co-Chair Will be upload soon
Keynote Sessions
Vaccines
Research &
Development
Sessions
Immunology
Bioprocessing & Manufacturing
Human Vaccines Non-Infectious diseases
Title: Does Bacterial Translocation Play a Role in the Pathogenesis of Severe
Dengue?
Byron Martina, Artemis One Health Research Institute, Netherlands
Title: Pathogen and Host Evasion Genes Provides "Ready made tools" for
vaccine development
Michael E Parkhouse,Gulbenkian Institute of Science , Portugal
Title: Zika virus pathogenesis and subunit vaccines with improved efficacy
Lanying Du, Lindsley F. Kimball Research Institute, USA
Title: Expression of Clostridium perfringens epsilon-beta fusion toxin gene in
E. coli and its immunologic studies in mouse
Reza Pilehchian, Razi Vaccine and Serum Research Institute,Iran
Keynote sessions
Vaccines
Research &
Development
Sessions
Bacterial Vaccines
Anti Viral Vaccines
Vaccines against Viral Diseases
Session Chair Dr. Giulio Tarro, Italy
Session Co-chair Will be upload soon
Title: TBE Monitoring and Prophylaxis in Kazakhstan
Andrey M.Dmitrovskiy, National Science Center of Extremely Dangerous
Infections, Kazakhstan
Title: To be confirmed
Gloria G Guerrero Manriquez, University Autonome of Zacatecas, Zacatecas,
Mexico
10:00-10:30
17:45-18:15
Day 2 February 11, 2020
16:15-16:45
10:30-11:00
15:20-16:00
16:45-17:15
17:15-17:45

3. Title: Prioritizing Vaccine Research and Development Needs for Equitable
Vaccine Delivery
Ibrahim Dadari, UNICEF Pacific Multi Country Office, Fiji
11:30-11:45 @Coffee Break
Oral Sessions
Title: Effictiveness of BCG Vaccination Against Latent Tuberculosis
Birger Trollfors, Department of Pediatrics, Swedan
Title: Haemophilus influenzae Serotype b Vaccines: Public Health Impact in
Prevention of Invasive Disease
Maria Paula Bajanca Lavado, National Institute of Health, Portugal
Title: Clinical And Immunogenetic Features In The Patient’s Multiple
Myeloma And Donors Hematopoietic Stem Cells And Their Effective Solution
Medical-Social And Economic-Legal Aspect
Baratova Dzhamilya Abdumazhitovna, Eurasian Сenter Oncohematology,
Immunology And Therapy, Russia
12:45-13:00 Panel Discussion
13:00-14:00 @Lunch Break
Title: The Problems of Brucellosis Vaccination in Kazakhstan
Svetlana F. Daulbayeva, Kazakh Russian Medical University, , Kazakhstan
Title: Examining Responses to Yellow Fever and Measles Vaccines in African
Infants
Olubukola T. Idoko, Medical Research Council, Gambia
Title: Development Of The Protocols For Manufacture And Application Of The
Three Herpesviral Vaccines For Treatment And Control Of Recurrences In
Herpes Simplex, Human Cytomegalovirus Infection And Herpes Zoster
Igor F. Barinsky, Ministry of Health of Russian Federation, Russia
Title: Comparative Study Between LAL Test And Pyrogen Test For Endotoxin
Detection
Mohammed Elkhateeb, Egyptian National Regulatory Authority
Egypt
Title: Immunization Cluster Surveys: The Best Approach To Assess
Immunization Programs
Fateh Azmatullah, Public Health Specialist, WHO Turkey
Title: Evaluation Of Vaccine Logistics Performance at Health Facilities in Ilala
Municipality, Tanzania
Bonaventura N. Muhindi, Ministry of Health, Tanzania
11:45-12:05
11:00-11:30
15:20-15:40
12:05-12:25
12:25-12:45
14:40-15:00
15:00-15:20
14:00-14:20
14:20-14:40
15:40-16:00

4. 16:00-16:15 @Coffee Break
Title: Next Generation Sequencing (NGS) Investigations: Multiple Pathogens
Detected In Suspected Dengue Patients
Kirk Osmond Douglas, University of the West Indies, West Indies
Title: Tryptophan, Kynurenine And Neopterin Serum Levels During Dengue
Virus Infection
Simon D Lytton, SeraDiaLogistics, Germany
Title: Dengue Fever and Severe Dengue in Barbados, 2008-2016
Kirk Osmond Douglas, University of the West Indies, West Indies
Title: Biomimicry Of The Cystic Fibrosis Bacterial-Host Interactions: Focus On
Common Bacterial Pathogens
Mafora G. Ngoepe, University of Pretoria, South Africa
Title: Likely HIV Resistance In Seronegative Partners Of Serodiscordant
Couples Induced By CD107a Proteins In The Presence Of High Viral Load And
In the Absence Of Condom Use
Abdou Padane, The Institute for Health Research, Epidemiological
Surveillance and Training (IRESSEF), Senegal
Title: Barriers to participation in Vaccine Trials among Adults in Abuja
Nigeria
Afoke Kokogho, Henry M. Jackson Foundation, Nigeria
Title: Evidence Of Significant T-Cell Mediated Immunity To Influenza
Infection In A Population-Based Cohort Study
Vincent T. Chow, National University of Singapore, Singapore
Title: Outbreak Investigation Of Cutaneous Leishmaniasis (CL) In North
Waziristan Agency, Federally Administered Tribal Area (FATA)
Faisal Shah, Directorate of Health Services KP, Pakistan
**Speakers, Poster and Delegate Slots are available**
17:15-17:35
17:35-17:55
17:55-18:15
***Note: This is a Tentative Program, it is Subjected to slight changes till Final Program
P-001
P-002
Poster Presentations on Day 2
16:55-17:15
16:35-16:55
16:15-16:35

5. Venue attractions
Speaker Banners